The accurate assessment of drinking by patients with alcoholic liver disease is important both before and after liver transplantation.
Unfortunately, self-reports by these individuals often underestimate their actual alcohol consumption.
Dr John Allen and colleagues report that several recently developed biochemical measures can provide additional information on a patient's use of alcohol.
|Ethyl glucuronide is a biomarker of drinking|
|Liver Transplantation |
The researchers describe ethyl glucuronide, ethyl sulfate, phosphatidyl ethanol, and carbohydrate-deficient transferrin as biomarkers of drinking.
The team summarizes research dealing with their application in patients with alcohol use disorders who are candidates for or recipients of liver transplantation.
Dr Allen's team concluded, "The article also offers suggestions for enhancing the reliability of self-report measures of drinking status."